Zymeworks (ZYME) Enterprise Value (2021 - 2026)
Zymeworks recorded quarterly Enterprise Value of -$364.7 million in Q1 2026, down 59.41% quarter-over-quarter from -$228.8 million in Q4 2025, and down 37.48% year-over-year from -$583.4 million in Q1 2025.
Zymeworks' Enterprise Value history runs 6 years deep, the most recent figure standing at -$364.7 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 37.48% year-over-year to -$364.7 million; the TTM figure through Mar 2026 stood at -$364.7 million (down 37.48% YoY), while the FY2025 annual figure was -$228.8 million, down 1.34% from the prior year.
- Enterprise Value came in at -$364.7 million for Q1 2026 at Zymeworks, down from -$228.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$166.2 million in Q3 2022 to a low of -$492.2 million in Q4 2022.
- A 5-year average of -$306.6 million and a median of -$297.2 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value tumbled 94.86% in 2022 and soared 39.68% in 2024, its largest moves.
- Zymeworks' Enterprise Value stood at -$492.2 million in 2022, then advanced by 23.95% to -$374.3 million in 2023, then surged by 39.68% to -$225.8 million in 2024, then fell by 1.34% to -$228.8 million in 2025, then tumbled by 59.41% to -$364.7 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$364.7 million, -$228.8 million, and -$251.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | -364.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -364.73 Mn |
| Dec 31, 2025 | -228.80 Mn |
| Sep 30, 2025 | -251.93 Mn |
| Jun 30, 2025 | -281.38 Mn |
| Mar 31, 2025 | -265.29 Mn |
| Dec 31, 2024 | -225.78 Mn |
| Sep 30, 2024 | -297.20 Mn |
| Jun 30, 2024 | -330.15 Mn |
| Mar 31, 2024 | -345.05 Mn |
| Dec 31, 2023 | -374.33 Mn |
| Sep 30, 2023 | -295.41 Mn |
| Jun 30, 2023 | -340.09 Mn |
| Mar 31, 2023 | -340.79 Mn |
| Dec 31, 2022 | -492.23 Mn |
| Sep 30, 2022 | -166.24 Mn |
| Dec 31, 2021 | -252.61 Mn |